VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 143 filers reported holding VIKING THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.72 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,859,848 | -54.0% | 890,682 | -32.6% | 0.00% | -50.0% |
| Q2 2023 | $21,413,038 | +46.4% | 1,320,977 | +50.3% | 0.00% | 0.0% |
| Q1 2023 | $14,628,873 | +168.0% | 878,611 | +51.3% | 0.00% | +100.0% |
| Q4 2022 | $5,459,174 | +402.7% | 580,763 | +45.5% | 0.00% | – |
| Q3 2022 | $1,086,000 | -43.2% | 399,241 | -39.6% | 0.00% | – |
| Q2 2022 | $1,912,000 | +78.7% | 661,168 | +85.5% | 0.00% | – |
| Q1 2022 | $1,070,000 | +3.5% | 356,504 | +58.7% | 0.00% | – |
| Q4 2021 | $1,034,000 | -36.1% | 224,643 | -12.8% | 0.00% | – |
| Q3 2021 | $1,617,000 | -39.8% | 257,739 | -42.5% | 0.00% | – |
| Q2 2021 | $2,687,000 | +249.0% | 448,591 | +268.8% | 0.00% | – |
| Q1 2021 | $770,000 | +58.8% | 121,637 | +41.3% | 0.00% | – |
| Q4 2020 | $485,000 | -75.7% | 86,079 | -74.9% | 0.00% | – |
| Q3 2020 | $1,994,000 | +63.2% | 342,724 | +102.3% | 0.00% | – |
| Q2 2020 | $1,222,000 | +227.6% | 169,404 | +112.1% | 0.00% | – |
| Q1 2020 | $373,000 | -79.8% | 79,883 | -65.3% | 0.00% | – |
| Q4 2019 | $1,848,000 | +87.2% | 230,451 | +60.8% | 0.00% | – |
| Q3 2019 | $987,000 | -4.6% | 143,354 | +14.9% | 0.00% | – |
| Q2 2019 | $1,035,000 | -28.2% | 124,758 | -13.9% | 0.00% | – |
| Q1 2019 | $1,441,000 | -53.9% | 144,932 | -64.6% | 0.00% | -100.0% |
| Q4 2018 | $3,129,000 | +13.3% | 409,088 | +158.0% | 0.00% | 0.0% |
| Q3 2018 | $2,762,000 | +196.7% | 158,550 | +61.6% | 0.00% | – |
| Q2 2018 | $931,000 | +1562.5% | 98,136 | +661.9% | 0.00% | – |
| Q1 2018 | $56,000 | +2700.0% | 12,881 | +1518.2% | 0.00% | – |
| Q1 2017 | $2,000 | -94.7% | 796 | -97.5% | 0.00% | – |
| Q4 2016 | $38,000 | +3700.0% | 31,278 | +5010.8% | 0.00% | – |
| Q3 2016 | $1,000 | 0.0% | 612 | +2.9% | 0.00% | – |
| Q2 2016 | $1,000 | – | 595 | +3400.0% | 0.00% | – |
| Q1 2016 | $0 | – | 17 | 0.0% | 0.00% | – |
| Q4 2015 | $0 | – | 17 | +6.2% | 0.00% | – |
| Q2 2015 | $0 | – | 16 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| APIS CAPITAL ADVISORS, LLC | 148,000 | $1,638,360 | 2.12% |
| Sio Capital Management, LLC | 595,002 | $6,586,672 | 2.04% |
| 5AM Venture Management, LLC | 585,000 | $6,475,950 | 1.86% |
| Artia Global Partners LP | 383,580 | $4,246,231 | 1.76% |
| Integral Health Asset Management, LLC | 800,000 | $8,856,000 | 1.23% |
| Boxer Capital, LLC | 2,000,000 | $22,140,000 | 1.18% |
| DAFNA Capital Management LLC | 319,655 | $3,538,581 | 1.10% |
| Affinity Asset Advisors, LLC | 332,600 | $3,681,882 | 1.04% |
| MPM BioImpact LLC | 325,000 | $3,597,750 | 0.96% |
| Affinity Asset Advisors, LLC | 300,000 | $3,321,000 | 0.93% |